» Articles » PMID: 27434871

Integrated Review of Barriers to Cervical Cancer Screening in Sub-Saharan Africa

Overview
Publisher Wiley
Specialty Nursing
Date 2016 Jul 20
PMID 27434871
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim of this study was to review published studies to identify and describe barriers to Papanicolaou (Pap) smear screening among women in sub-Saharan Africa.

Design And Methods: Guided by Cooper's integrative review methodology, studies published between 2006 and 2015 were identified by searching electronic databases: Cumulative Index to Nursing and Allied Health Literature (CINAHL), PubMed, MEDLINE, ProQuest, and PsycINFO using specified search terms. Using this strategy, 224 articles were identified and screened for duplication and by reading titles, abstracts, and full texts. Seventeen articles met the inclusion criteria and were appraised using relevant tools for qualitative and quantitative designs. No relevant articles published in 2006, 2007, and 2014 were found.

Findings: All 17 articles had good methodological quality and were included in the review. The studies were from 10 sub-Saharan countries and from different settings. Content analysis of the data revealed three major themes coded as client, provider, and system barriers. The most common client barriers were lack of knowledge and awareness about Pap smear screening, fear of cancer, belief of not being at risk for cervical cancer, and that a Pap smear is not important unless one is ill and cultural or religious factors. Provider barriers were failure to inform or encourage women to screen. Major system barriers were unavailability and inaccessibility of the Pap test.

Conclusions: The review provided evidence of barriers to Pap smear screening among sub-Saharan women. Although there were some variations from country to country, sub-Saharan countries share similar constraints to Pap smear screening. These findings have important implications for practice and policy.

Clinical Relevance: Understanding the client, provider, and system barriers to cervical cancer screening could guide development of effective interventions.

Citing Articles

Bridging the Gap: Immune Checkpoint Inhibitor as an Option in the Management of Advanced and Recurrent Cervical Cancer in Sub-Saharan Africa.

Okpalanwaka I, Anazodo F, Chike-Aliozor Z, Ekweozor C, Ochie K, Oboh O Cureus. 2024; 16(9):e69136.

PMID: 39398762 PMC: 11467442. DOI: 10.7759/cureus.69136.


Uptake of cervical cancer screening and associated factors among HIV positive women attending adult art clinic at public hospitals in Addis Ababa, Ethiopia, 2022.

Zegeye F, Legasu T, Bayou F, Ali M BMC Womens Health. 2024; 24(1):377.

PMID: 38943118 PMC: 11212152. DOI: 10.1186/s12905-024-03169-x.


Experiences of women participating in a human papillomavirus-based screen-triage-and treat strategy for cervical cancer prevention in Malawi.

Lee F, McGue S, Chapola J, Dunda W, Tang J, Ndovie M Front Oncol. 2024; 14:1356654.

PMID: 38476363 PMC: 10927745. DOI: 10.3389/fonc.2024.1356654.


Barriers to cervical cancer screening in Africa: a systematic review.

Mantula F, Toefy Y, Sewram V BMC Public Health. 2024; 24(1):525.

PMID: 38378542 PMC: 10877795. DOI: 10.1186/s12889-024-17842-1.


Cervical cancer screening uptake and associated factors among Women Living with in public hospitals, eastern Ethiopia.

Tesfaye D, Weldegebreal F, Ayele F, Dheresa M Front Oncol. 2023; 13:1249151.

PMID: 37965474 PMC: 10642187. DOI: 10.3389/fonc.2023.1249151.